Dental Care Clinics in Wmsvl, NY Accepting Medicare
1 Dental Care Clinics found. Showing 1 - 1
 Nancy Mufalli Dds Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 5782 Main Street, Suite 4, Wmsvl, NY 14221 Phone: 716-630-1600 Fax: 716-204-3589 |
News Archive
Study supports nurses as key contributors to hospital patients' satisfaction with pain control
Hospital patients' satisfaction with pain management is linked to nurse staffing, according to an article authored by nurse researchers from the Connell School of Nursing at Boston College and published in the journal Pain Management Nursing.
Positive interim results from Inspiration's OBI-1 Phase 2/3 study for acquired hemophilia A
Inspiration Biopharmaceuticals, Inc. today reported data from its ongoing Phase 2/3 study evaluating the efficacy of OBI-1, an investigational recombinant porcine factor VIII (FVIII), for the treatment of serious bleeds in people with acquired hemophilia A. According to the interim analysis, seven out of seven trial participants receiving OBI-1 experienced control and subsequent resolution of their bleeds.
Salk professor receives inaugural Sjöberg Prize for groundbreaking cancer research
Salk Professor Tony Hunter, who holds an American Cancer Society Professorship, has been awarded $500,000 as part of the $1 million Royal Swedish Academy of Sciences' inaugural Sjöberg Prize for Cancer Research for "groundbreaking studies of cellular processes that have led to the development of new and effective cancer drugs."
Russian researchers create intelligent software system for lung cancer diagnostics
Researches from Peter the Great St.Petersburg Polytechnic University, Russian Academic Excellence Initiative participant, in collaboration with the radiologists from St.Petersburg Clinical Research for Specialized Types of Medical Care have developed an intelligent software system for lung cancer diagnostics.
AcelRx announces top-line data from Sufentanil NanoTab PCA System Phase 3 trial
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that top-line data from its previously announced open-label, active-comparator study of its lead product candidate, the Sufentanil NanoTab PCA System, will be featured in poster presentations to be held at the 66th annual New York State Society of Anesthesiologists PostGraduate Assembly meeting in New York City to be held December 14-18, 2012.
› Verified 7 days ago